WHO ICTRP trial
Randomized, Double-blind, Multicenter study to compare the safety and efficacy…
EUCTR2004-000408-41-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2004-000408-41-IT |
|---|---|
| Public title | Randomized, Double-blind, Multicenter study to compare the safety and efficacy of Viramidine to Ribavirin in Treatment-Naive patients with Chronic Hepatitis C |
| Scientific title | Randomized, Double-blind, Multicenter study to compare the safety and efficacy of Viramidine to Ribavirin in Treatment-Naive patients with Chronic Hepatitis C |
| Primary sponsor | RIBAPHARM |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | Chronic Hepatitis C MedDRA version: 6.1 Level: PT Classification code 10019744 |
| Interventions | Product Name: Viramidine Product Code: RNA003142 Pharmaceutical Form: Film-coated tablet CAS Number: 40372-00-7 Current Sponsor code: RNA003142 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 200- Trade… |
| Registration date | Jun 28, 2005 |
| Secondary IDs | RNA003142-302 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: